Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Dallas, Texas


A study to compare the rate of complete wound closure and quality of resulting scar at 3, 6 and 9 months, between dermatome-induced skin wounds treated with Collagenase Santyl Ointment versus vehicle alone.


Inclusion Criteria: 1. Provide written informed consent 2. Willing to attend all required study visits Exclusion Criteria: 1. Known hypersensitivity to Clostridial collagenase 2. Anticoagulants (blood thinners, including aspirin) within two weeks 3. Congenital skin disorder which affects keratinocytes, elastin, or collagen 4. Any dermatologic disease which may be aggravated or provoked by the wounding procedure 5. Dark skin pigmentation to a degree which is very likely to obscure the assessment of vascularization post-wounding 6. At risk of keloid or hypertrophic scar formation 7. Scars, tattoos or deformities (i.e., contractures) on the inner aspect of the upper arm area where the wound will be placed 8. Any skin disorder which causes delayed healing 9. Disrupted lymphatic drainage of the arm to be studied, or previously diagnosed thoracic outlet syndrome 10. Taking concomitant medications at doses which are known to interfere with healing, such as non-steroidal anti-inflammatory drugs, anti-neoplastic drugs, or immunosuppressive drugs



Primary Contact:

Study Director
Herbert B Slade, MD

Backup Contact:


Location Contact:

Dallas, Texas
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.